Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis

NCT00548249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

End-Stage Renal Disease (ESRD)

Interventions

DEVICE: Standard Bicarbonate Solution
DRUG: Soluble Ferric Pyrophosphate
DRUG: Soluble Ferric Pyrophosphate
DRUG: Soluble Ferric Pyrophosphate
DRUG: Soluble Ferric Pyrophosphate

Sponsor

Rockwell Medical Technologies, Inc.